Useful insight required4 Oct 2020 10:16
Morning all, I am currently a holder in HEMO and considering putting a larger sum in at some point after doing further research. As a chartered accountant, the interim report looks optimistic and positive especially with the comments from the Board. I have also been reading the broker report by SP Angel issued in July. Following my research to date, I have a few questions which I hope the genuine long term holders can help to answer:
1) Hemo have had two placings this year raising £3.2m to date. The interim report states ‘Hemo may elect to raise additional capital within the next year’ and ‘stockholders may experience dilution’. What are your thoughts on this? How frequently is cash typically burnt in a pre-clinical pharma company?
2) CDX - we are working with a ‘Globalco’. Do we have any indication of who this Globalco could be and a timeline of a potential deal to be signed? Is this Eli and Lilly?
3) how long has the deal with Eli and Lilly be signed for?
Finally, what do you envisage as the next major news we expect to receive?
Thanks in advance and good luck.